~~<i id='F0A6EFB652'><strike id='F0A6EFB652'><tt id='F0A6EFB652'><pre id='F0A6EFB652'></pre></tt></strike></i>~~

Home» comprehensive» focus

focus

author：focus 2025-09-30 23:00:56 Page View：68428

Martin Shkreli Securities Fraud Trial — Kevin Hagen/Getty Images

Is this the end of the line for the “pharma bro” with the perpetual smirk?

Martin Skhreli was found guilty on Friday of three counts of fraud after a five-week trial in federal court in Brooklyn, N.Y. He faces a prison sentence that could stretch years.

“This was a witch hunt of epic proportions,” Shkreli said outside court after the verdict, the Washington Post reported. “They may have found some broomsticks.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save health care price transparency rules
Next article： Psychedelics group wrestles with new pharma identity

explore

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

The explosion of genetic testing requires a new approach

AtechnicianplacesanarraycontainingDNAinformationinascanner.GREGBAKER/AFPviaGettyImagesNewtechnologyh

Heart attack and stroke risk calculators need revising

AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

First U.S. drug developed to treat liver disease MASH is approved

AdobeTheFoodandDrugAdministrationonThursdayapprovedthefirstmedicinedevelopedspecificallytotreatthese